Context Bladder management in spina bifida patients relies on clean intermittent
catheterization and oral antimuscarinics with a significant failure rate. The efficacy of …

Neurogenic bladder dysfunction (NB) represents a challenge in pediatric urology.
Intravesical botulin toxin-A (BTX-A) bladder injection is part of the armamentarium for the …

Neurogenic detrusor overactivity (NDO) is a bladder dysfunction caused by a neurologic
disease such as multiple sclerosis (MS), spinal cord injury (SCI), Parkinson's disease (PD) …

Purpose Lower urinary tract symptoms (LUTS) are bothersome constellation of voiding
symptoms in men and women as they age. Multiple factors and comorbidities are attributed …

Introduction Botulinum toxin injection (BTI) has been advocated as a second line therapy in
management of neuropathic bladder in pediatric population for refractory patients to …

Special birth defects and neurological diseases can cause neurogenic detrusor overactivity
(NDO). First-line pharmacotherapy is the antimuscarinic therapy, which can be limited by …

Objective This study aimed to determine the effectiveness of intradetrusor injections of
onabotulinum toxin-A (BoNT-A) in pediatric patients with neurogenic bladders (NB) due to …

Objective To determine the efficacy and safety of repeated intradetrusor onabotulinum toxin
A (onaBoNT-A) injections in children with neurogenic detrusor overactivity due to …

Children and young people with neurodisability often need help to achieve socially
acceptable bladder and bowel control. Approaches vary depending on whether or not the …

Purpose We retrospectively evaluated the efficacy of botulinum neurotoxin A (BoNT-A) on
vesicoureteral reflux (VUR), continence status, and urodynamic parameters in children with …